Timing is everything: Celgene posts volume-driven growth in Q2 as industry faces pricing opposition

26th July 2018 Uncategorised 0

Celgene is extracting volume-driven sales growth as the entire industry has come under scrutiny for its pricing. For the big biotech, the performance comes as it looks to move past setbacks that have hurt share price.

More: Timing is everything: Celgene posts volume-driven growth in Q2 as industry faces pricing opposition
Source: fierce